Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 1
1992 1
1995 2
1996 1
1997 2
1999 2
2000 3
2001 2
2002 3
2003 4
2004 2
2005 3
2006 3
2007 3
2008 5
2009 3
2010 3
2011 6
2012 7
2013 7
2014 9
2015 6
2016 10
2017 6
2018 10
2019 9
2020 7
2021 9
2022 11
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Results by year

Filters applied: . Clear all
Page 1
Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial.
Koole S, van Stein R, Sikorska K, Barton D, Perrin L, Brennan D, Zivanovic O, Mosgaard BJ, Fagotti A, Colombo PE, Sonke G, Driel WJV; OVHIPEC-2 Steering Committee and the Dutch OVHIPEC group. Koole S, et al. Int J Gynecol Cancer. 2020 Jun;30(6):888-892. doi: 10.1136/ijgc-2020-001231. Epub 2020 Mar 23. Int J Gynecol Cancer. 2020. PMID: 32205449 Free PMC article.
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial.
Aronson SL, Lopez-Yurda M, Koole SN, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, de Hingh IHJT, van Gent MDJM, Arts HJG, van Ham MAPC, van Dam PA, Vuylsteke P, Aalbers AGJ, Verwaal VJ, Van de Vijver KK, Aaronson NK, Sonke GS, van Driel WJ. Aronson SL, et al. Among authors: van ham mapc. Lancet Oncol. 2023 Oct;24(10):1109-1118. doi: 10.1016/S1470-2045(23)00396-0. Epub 2023 Sep 11. Lancet Oncol. 2023. PMID: 37708912 Clinical Trial.
Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial.
Koole SN, Schouten PC, Hauke J, Kluin RJC, Nederlof P, Richters LK, Krebsbach G, Sikorska K, Alkemade M, Opdam M, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, de Hingh IHJT, Mom CH, Arts HJG, van Ham M, van Dam P, Vuylsteke P, Sanders J, Horlings HM, van de Vijver KK, Hahnen E, van Driel WJ, Schmutzler R, Sonke GS, Linn SC. Koole SN, et al. Among authors: van ham m. Int J Cancer. 2022 Oct 15;151(8):1394-1404. doi: 10.1002/ijc.34124. Epub 2022 Jun 4. Int J Cancer. 2022. PMID: 35583992 Free article. Clinical Trial.
Clinical management of uterine papillary serous carcinoma.
Roelofsen T, van Ham MA, de Hullu JA, Massuger LF. Roelofsen T, et al. Among authors: van ham ma. Expert Rev Anticancer Ther. 2011 Jan;11(1):71-81. doi: 10.1586/era.10.199. Expert Rev Anticancer Ther. 2011. PMID: 21166512 Review.
An overview of Clinical Quality Registries (CQRs) on gynecological oncology worldwide.
Baldewpersad Tewarie N, van Driel WJ, van Ham MAPC, Wouters MW, Rome RM, Høgdall CK, Pagano E, Hogberg T, Kruitwagen R; participants of the - Dutch Gynecological Oncology Group. Baldewpersad Tewarie N, et al. Among authors: van ham mapc. Eur J Surg Oncol. 2022 Oct;48(10):2094-2103. doi: 10.1016/j.ejso.2022.06.020. Epub 2022 Jun 23. Eur J Surg Oncol. 2022. PMID: 35931589 Free article. Review.
What to do with HLA-DO?
van Ham M, van Lith M, Griekspoor A, Neefjes J. van Ham M, et al. Immunogenetics. 2000 Aug;51(10):765-70. doi: 10.1007/s002510000208. Immunogenetics. 2000. PMID: 10970090 Review.
PDZ domains-glue and guide.
van Ham M, Hendriks W. van Ham M, et al. Mol Biol Rep. 2003 Jun;30(2):69-82. doi: 10.1023/a:1023941703493. Mol Biol Rep. 2003. PMID: 12841577 Review.
Functional analysis of the anti-adalimumab response using patient-derived monoclonal antibodies.
van Schouwenburg PA, Kruithof S, Votsmeier C, van Schie K, Hart MH, de Jong RN, van Buren EE, van Ham M, Aarden L, Wolbink G, Wouters D, Rispens T. van Schouwenburg PA, et al. Among authors: van ham m. J Biol Chem. 2014 Dec 12;289(50):34482-8. doi: 10.1074/jbc.M114.615500. Epub 2014 Oct 17. J Biol Chem. 2014. PMID: 25326381 Free PMC article. Review.
133 results